4.6 Article

miRNA dysregulation is an emerging modulator of genomic instability

Journal

SEMINARS IN CANCER BIOLOGY
Volume 76, Issue -, Pages 120-131

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2021.05.004

Keywords

Genomic instability; Chromosomal instability; miRNA; DNA repair

Categories

Funding

  1. National Institute of Environmental Health Sciences [R21ES030334, R01ES027778, P30ES030283, T32ES011564]

Ask authors/readers for more resources

Genomic instability, caused by genetic alterations, leads to tumor heterogeneity and drug resistance, resulting from defects in DNA damage surveillance mechanisms and repair machinery. miRNA dysregulation may play a crucial role in mediating genome instability and carcinogenesis.
Genomic instability consists of a range of genetic alterations within the genome that contributes to tumor heterogeneity and drug resistance. It is a well-established characteristic of most cancer cells. Genome instability induction results from defects in DNA damage surveillance mechanisms, mitotic checkpoints and DNA repair machinery. Accumulation of genetic alterations ultimately sets cells towards malignant transformation. Recent studies suggest that miRNAs are key players in mediating genome instability. miRNAs are a class of small RNAs expressed in most somatic tissues and are part of the epigenome. Importantly, in many cancers, miRNA expression is dysregulated. Consequently, this review examines the role of miRNA dysregulation as a causal step for induction of genome instability and subsequent carcinogenesis. We focus specifically on mechanistic studies assessing miRNA(s) and specific subtypes of genome instability or known modes of genome instability. In addition, we provide insight on the existing knowledge gaps within the field and possible ways to address them.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Toxicology

Urolithin A attenuates arsenic-induced gut barrier dysfunction

Sweta Ghosh, Mayukh Banerjee, Bodduluri Haribabu, Venkatakrishna Rao Jala

Summary: Environmental chemicals like iAs can increase oxidative stress in the body, disrupting gut homeostasis, but gut microbiota are essential to protect against its toxicity, with microbial metabolites such as UroA potentially providing protection against environmental hazards by reducing oxidative stress and enhancing gut barrier function.

ARCHIVES OF TOXICOLOGY (2022)

Article Environmental Sciences

Temporal Modulation of Differential Alternative Splicing in HaCaT Human Keratinocyte Cell Line Chronically Exposed to Arsenic for up to 28 Wk

Ana P. Ferragut Cardoso, Mayukh Banerjee, Laila Al-Eryani, Mohammed Sayed, Daniel W. Wilkey, Michael L. Merchant, Juw W. Park, J. Christopher States

Summary: Chronic arsenic exposure is linked to increased cancer risk. This study aimed to profile alternative splicing events in human keratinocytes induced by arsenic. Results suggest arsenic exposure may disrupt an alternative splice factor network and induce genome-wide alternative splicing contributing to arsenic-induced carcinogenesis.

ENVIRONMENTAL HEALTH PERSPECTIVES (2022)

Article Toxicology

Delineating the Effects of Passaging and Exposure in a Longitudinal Study of Arsenic-Induced Squamous Cell Carcinoma in a HaCaT Cell Line Model

Mayukh Banerjee, Laila Al-Eryani, Sudhir Srivastava, Shesh N. Rai, Jianmin Pan, Theodore S. Kalbfleisch, J. Christopher States

Summary: This study performed longitudinal differential expression analysis of miRNA and mRNA in a HaCaT cell line model of arsenic-induced cutaneous squamous cell carcinoma (cSCC). The results showed differential expression of miRNA and mRNA molecules depending on the time points, with some pathways predicted to be modulated as a function of time or arsenic exposure. The HaCaT model can distinguish between the effects of passaging and chronic arsenic exposure individually.

TOXICOLOGICAL SCIENCES (2022)

Meeting Abstract Biochemistry & Molecular Biology

Microbial metabolite mitigates arsenic induced oxidative stress, inflammation, and barrier dysfunction in gut epithelia

Sweta Ghosh, Mayukh Banerjee, Haribabu Bodduluri, Venkatakrishna Rao Jala

FASEB JOURNAL (2022)

Editorial Material Toxicology

2020-2021 Toxicological Sciences Paper of the Year

J. Christopher States, Jeffrey M. Peters

TOXICOLOGICAL SCIENCES (2022)

Article Environmental Sciences

Zinc supplementation prevents arsenic-induced dysregulation of ZRANB2 splice function

Jonathan C. Bastick, Mayukh Banerjee, J. Christopher States

Summary: Inorganic arsenic exposure can displace zinc from zinc fingers of the splice regulator ZRANB2, disrupting its role in the splicing of its target TRA2B. However, zinc supplementation can prevent the disruption of ZRANB2 splice function caused by iAs, suggesting a potential preventive measure against iAs-mediated diseases.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Chronic arsenic exposure suppresses ATM pathway activation in human keratinocytes

Alexandra N. Nail, Lakynkalina M. McCaffrey, Mayukh Banerjee, Ana P. Ferragut Cardoso, J. Christopher States

Summary: An estimated 220 million people worldwide are chronically exposed to inorganic arsenic (iAs), which can lead to skin lesions and multi-organ cancers. This study suggests that chronic iAs exposure inhibits DNA repair and damage response signaling, leading to error-prone repair pathways and chromosomal instability.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Zinc supplementation prevents mitotic accumulation in human keratinocyte cell lines upon environmentally relevant arsenic exposure

Mayukh Banerjee, Kavitha Yaddanapudi, J. Christopher States

Summary: This study demonstrates that environmentally relevant exposure to inorganic arsenic (iAs) can disrupt the cell cycle and induce mitotic accumulation of cells. This effect may be mediated by the displacement of zinc from the RING finger subunit of the anaphase promoting complex/cyclosome (ANAPC11), leading to the stabilization of cyclin B1 and securin. Zinc supplementation can prevent this cell cycle disruption caused by iAs exposure.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2022)

Article Oncology

Human macrophage-engineered vesicles for utilization in ovarian cancer treatment

David Schweer, Namrata Anand, Abigail Anderson, J. Robert McCorkle, Khaga Neupane, Alexandra N. Nail, Brock Harvey, Kristen S. Hill, Frederick Ueland, Christopher Richards, Jill Kolesar

Summary: Ovarian cancer is a deadly female malignancy characterized by high rates of recurrence and chemotherapy resistance. Tumor-associated macrophages (TAMs) play a significant role in the tumor microenvironment and consist of mostly M2 protumor macrophages that promote chemo-resistance and metastasis. Vesicles engineered from M1 macrophages (MEVs) represent a novel therapeutic approach for converting M2 macrophages to M1-like phenotype macrophages.

FRONTIERS IN ONCOLOGY (2023)

No Data Available